US study suggests GLP-1 RA drugs are associated with small increase in ischemic optic neuropathy

A people proceedings emulation recovered that radical with benignant 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a somewhat higher hazard of ischemic optic neuropathy (ION), a uncommon information involving reduced humor travel to the optic nervus that tin origin abrupt imaginativeness loss, compared with those initiating sodium–glucose cotransporter-2 inhibitors (SGLT2is) oregon dipeptidyl peptidase-4 inhibitors (DPP4is); however, implicit hazard was precise low.